ICMI 2015

OR.83 TGFβ Promotes the Development of CD103+ CD11B+ DCs in the Intestine

Friday, July 17, 2015: 4:00 PM
Hall Berlin C, Ground Floor (Maritim Hotel)
Jennifer Montgomery , University of Glasgow, Glasgow, United Kingdom
Calum Bain , MRC Centre for Inflammation Research, University of Edinburgh, Edinburgh, United Kingdom
Tamsin Zangerle Murray , University of Glasgow, Glasgow, United Kingdom
Allan Mowat, MD, PhD , University of Glasgow, Glasgow, Scotland, SCOTLAND
Dendritic cells (DC) play a key role in regulating intestinal immune responses. The intestine contains a unique subset of DCs that expresses both CD103 and CD11b, but it is unclear what factors in the local environment might drive the differentiation of such unusual DCs.

TGFβ is highly abundant in the intestine and induces the expression of CD103 on T cells. Here we show that deletion of the TGFβRI on CD11c+ cells leads to a selective defect in CD103+CD11b+ DCs in the small and large intestinal mucosa, with preserved numbers of CD103-CD11b+ DCs. The defect in CD103+CD11b+ DCs was cell intrinsic and was not due to altered migration of intestinal DCs, as identical reductions occurred in mucosa and draining lymph nodes. Isolated downregulation of CD103 does not explain the apparent defect, as microarray and phenotypic analyses showed reduced expression of other markers normally specific to this population, including Siglec F and TREM-1. Preliminary studies indicate that CD11b+ DCs from CD11c-cre-TGFβRI mice have a defective ability to induce the generation of FoxP3+ Treg. Together our data indicate that TGFβ plays a crucial role in the terminal differentiation of potentially tolerogenic CD103+CD11b+ DCs from a CD103-CD11b+ precursor in the intestine.